- Home
- AVBH vs SRZN Comparison
AVBH vs SRZN Comparison
Compare AVBH & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$31.23
Company Overview
Basic Information| Metric | AVBH | SRZN |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | United States | United States |
| Employees | 151 | 44 |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.3M | 323.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AVBH | SRZN |
|---|---|---|
| Price | $30.42 | $31.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $34.33 | ★ $38.00 |
| AVG Volume (30 Days) | 56.0K | ★ 118.1K |
| Earning Date | 04-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $350.70 | $75.35 |
| Revenue Next Year | $11.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.95 | $7.11 |
| 52 Week High | $31.61 | $33.96 |
Technical Indicators
Market Signals| Indicator | AVBH | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 67.17 | 55.60 |
| Support Level | $29.23 | $23.95 |
| Resistance Level | $31.41 | $33.96 |
| Average True Range (ATR) | 0.64 | 2.57 |
| MACD | 0.07 | -0.11 |
| Stochastic Oscillator | 67.90 | 67.16 |
Price Performance
Historical Comparison AVBH
SRZN
About AVBH Avidbank Holdings Inc.
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).